RE: Expecting an RNS wave and back to 30p into next year as more hospitals adopt5 Dec 2023 11:41
James brings extensive commercial and operational experience at a senior level through a successful career with established diagnostic companies such as Cepheid, Beckman Coulter, and Roche Diagnostics, as well as serving as an executive board member of the British In Vitro Diagnostics Association (BIVDA). The Board believes James' experience, especially his extensive involvement in selling into the NHS, will be valuable as the Company expands its commercial footprint and opportunities within the UK and more widely.
Unlocking doors one step at a time. Investor confidence growing. Hold on tight.